Kensington Investment Counsel’s Axonics, Inc. Common Stock AXNX Stock Holding History

Kensington Investment Counsel’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,504	Closed	-$924K	–	91
2021 Q4	$924K	Buy	+16,504	New	+$1.01M	0.54%	76
2021 Q2	$1.23M	Buy	19,392 +1,611	+9%	+$95.1K	0.84%	58
2021 Q1	$1.06M	Buy	+17,781	New	+$967K	0.8%	63

Other funds holding AXNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kensington Investment Counsel's AXNX Position: Q1 2022 in Review

Kensington Investment Counsel sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 16,504 shares — an estimated $924K sold.

Kensington Investment Counsel first reported a position in AXNX in Q1 2021 and held it in 3 quarters. The position peaked at $1.23M in Q2 2021. 186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

Kensington Investment Counsel reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Kensington Investment Counsel sold 16,504 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $924K.
Kensington Investment Counsel first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Kensington Investment Counsel's Axonics, Inc. Common Stock position peaked at $1.23M in Q2 2021.
186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Kensington Investment Counsel's 13F filing for Q1 2022, filed 13 May 2022.